FAMI
UTHR icon

Fideuram Asset Management (Ireland)’s United Therapeutics UTHR Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
+4,146
New +$2.33M 0.04% 470
2026
Q1 		– Sell
-1,040
Closed -$473K – 704
2025
Q4 		$473K Buy
+1,040
New +$484K 0.04% 321

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fideuram Asset Management (Ireland)'s UTHR Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) opened a new position in United Therapeutics (UTHR) in Q2 2026: 4,146 shares worth $2.25M. The stake represents 0.04% of the portfolio and ranks #470 among its holdings. This is a return to the name: Fideuram Asset Management (Ireland) previously reported a position in UTHR as recently as Q4 2025.

Fideuram Asset Management (Ireland) first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 4,146 shares of United Therapeutics worth $2.25M as of Q2 2026.
  • United Therapeutics was a new Fideuram Asset Management (Ireland) position in Q2 2026.
  • United Therapeutics made up 0.04% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #470 holding.
  • Fideuram Asset Management (Ireland) first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.